Göttsche Jennifer, Piffko Andras, Pantel Tobias F, Westphal Manfred, Dührsen Lasse, Czorlich Patrick, Sauvigny Thomas
Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Front Neurol. 2022 Mar 14;13:846066. doi: 10.3389/fneur.2022.846066. eCollection 2022.
The influence of preexisting factors on the clinical course of patients with subarachnoid hemorrhage (SAH), such as patient age, arterial hypertension, and aneurysm characteristics, is still a matter of debate. However, the specific impact of the exact aneurysm location has not received adequate attention. Therefore, the aim of this study was to investigate the influence of aneurysm location as a preexisting factor on the clinical course and mortality.
The data of consecutive patients with aneurysmal SAH who were treated from October 2010 to July 2020 were retrospectively analyzed. We distinguished four aneurysm locations: the anterior complex, internal carotid artery (ICA), middle cerebral artery (MCA), and posterior circulation. Logistic regression analysis and receiver operating characteristics were used to investigate the influence of aneurysm location on the occurrence of acute hydrocephalus, Delayed Cerebral Ischemia (DCI), neurological outcome, and in-hospital mortality. Neurological outcome was assessed 3 months after discharge using the Glasgow Outcome Scale.
A total of 603 patients were included in this study. Patients with MCA aneurysms were 2.52 times less likely to develop acute hydrocephalus compared to patients with anterior complex aneurysms ( = 0.001). Delayed cerebral ischemia occurred most frequently in patients with an anterior complex aneurysm and least frequently in MCA aneurysms ( = 0.014). In ICA aneurysms, mortality was 2.56-fold higher than in patients with aneurysms of the anterior complex ( = 0.006). An additional ROC analysis showed a good prediction for in-hospital mortality when taking the aneurysm's location into account [AUC.855 (CI.817 -0.893)].
The aneurysm's location proved to be a significant predictor of acute hydrocephalus, DCI, and in-hospital mortality, demonstrating the impact of this preexisting biological factor on the course of SAH.
诸如患者年龄、动脉高血压和动脉瘤特征等预先存在的因素对蛛网膜下腔出血(SAH)患者临床病程的影响仍存在争议。然而,动脉瘤确切位置的具体影响尚未得到充分关注。因此,本研究的目的是调查动脉瘤位置作为一个预先存在的因素对临床病程和死亡率的影响。
回顾性分析2010年10月至2020年7月期间接受治疗的连续性动脉瘤性SAH患者的数据。我们区分了四个动脉瘤位置:前循环复合体、颈内动脉(ICA)、大脑中动脉(MCA)和后循环。采用逻辑回归分析和受试者工作特征曲线来研究动脉瘤位置对急性脑积水、迟发性脑缺血(DCI)、神经功能结局和住院死亡率的影响。出院3个月后使用格拉斯哥预后量表评估神经功能结局。
本研究共纳入603例患者。与前循环复合体动脉瘤患者相比,MCA动脉瘤患者发生急性脑积水的可能性降低2.52倍(P = 0.001)。迟发性脑缺血在前循环复合体动脉瘤患者中最常见,在MCA动脉瘤患者中最少见(P = 0.014)。ICA动脉瘤患者的死亡率比前循环复合体动脉瘤患者高2.56倍(P = 0.006)。另一项ROC分析表明,考虑动脉瘤位置时对住院死亡率有良好的预测价值[AUC = 0.855(CI = 0.817 - 0.893)]。
动脉瘤位置被证明是急性脑积水、DCI和住院死亡率的重要预测指标,表明这一预先存在的生物学因素对SAH病程的影响。